Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aptevo Therapeutics (APVO) Total Debt (2016 - 2022)

Historic Total Debt for Aptevo Therapeutics (APVO) over the last 8 years, with Q4 2022 value amounting to $3.5 million.

  • Aptevo Therapeutics' Total Debt fell 7752.05% to $3.5 million in Q4 2022 from the same period last year, while for Dec 2022 it was $3.5 million, marking a year-over-year decrease of 7752.05%. This contributed to the annual value of $3.5 million for FY2022, which is 7752.05% down from last year.
  • As of Q4 2022, Aptevo Therapeutics' Total Debt stood at $3.5 million, which was down 7752.05% from $3.9 million recorded in Q3 2022.
  • Over the past 5 years, Aptevo Therapeutics' Total Debt peaked at $25.2 million during Q3 2020, and registered a low of $3.5 million during Q4 2022.
  • Moreover, its 5-year median value for Total Debt was $19.2 million (2018), whereas its average is $15.7 million.
  • Per our database at Business Quant, Aptevo Therapeutics' Total Debt soared by 2786.83% in 2020 and then crashed by 7752.05% in 2022.
  • Aptevo Therapeutics' Total Debt (Quarter) stood at $19.3 million in 2018, then increased by 3.03% to $19.9 million in 2019, then rose by 26.13% to $25.1 million in 2020, then plummeted by 38.64% to $15.4 million in 2021, then plummeted by 77.52% to $3.5 million in 2022.
  • Its last three reported values are $3.5 million in Q4 2022, $3.9 million for Q3 2022, and $4.4 million during Q2 2022.